NCT00665639View on ClinicalTrials.gov

Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Candidiasis, Oral
Interventions
DRUG

micafungin

IV

DRUG

caspofungin

IV

Trial Locations (31)

Unknown

5 Sites, Buenos Aires

Córdoba

Neuquén

Santa Fe

Barretos

3 Sites, Belo Horizonte

Boqueirao-Santos

Campinas

2 Sites, Curitiba

Nova Iguaçu

Parquelandia-Fortaleza

7 Sites, São Paulo

4 Sites, Lima

Gaborone

Windoek

Arcadia-Pretoria

Benoni

2 Sites, Bloemfontein

Cape Town

Centurion

Dundee

Durban

Hatfield-Pretoria

Olifantsfontein

2 Sites, Port Elizabeth

Potchefstroom

Pretoria

Pretoria West

Reiger Park

Richards Bay

Somerset West

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY